This deregulation is characterized by an increased labile iron pool (LIP), upregulation of transferrin receptor (TfR) expression on the cytoplasmic membrane, and specific modulation of iron regulatory proteins (IRPs), particularly IRP2, which serves as a key regulator of iron metabolism in tumor cells [6,7,8,9]. This evidence concerns the gene IREB2 and neoplasm.